NIH-funded research R01 grant

Neonatal Brain Injury Protection with New Purine Compounds

Official title: Neuroprotective Strategy: Novel Purine Derivatives for Neonatal Hypoxia-ischemia

Funded at Women and Infants Hospital-Rhode Island · NIH-11541249 · Data updated 2026-11-12

A new medication approach using purine derivatives is being studied to protect newborn brains from injury caused by limited blood flow and oxygen during birth.

More Hypoxia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWomen and Infants Hospital-Rhode Island
NIH-funded
Lab location1 site (Providence, United States)
Project startMay 1, 2021
Project endJanuary 31, 2027
Funding year2026
Award (this year)$151,138
NIH project number3R01NS117428-05S1
Project IDNIH-11541249 on NIH RePORTER

Who could benefit from this research

Could help

Newborns who have experienced hypoxia-ischemia around birth and meet the study's eligibility criteria.

Less likely to help

Some infants may not respond to the treatment or could experience side effects.

What this research studies

This project focuses on babies who suffer hypoxia-ischemia around birth, a condition that can lead to long-term brain damage. Researchers will test a new family of purine-based molecules that act on specific brain cell pathways to stabilize mitochondria and reduce inflammation after injury. The work builds on animal data showing cognitive and neural benefits, and aims to translate those findings to newborns using established neonatal injury models. The study will examine how these compounds influence the blood-brain barrier, inflammation, and neuronal survival in the developing brain.

Why it matters

Potential benefit: If successful, the approach could lessen brain injury and improve neurodevelopmental outcomes after neonatal HI.

How similar studies have gone: Preclinical data in mice suggest neuroprotection and improved brain function with purine derivatives, supporting the potential for human benefit.

Where this research is happening

  • Women and Infants Hospital-Rhode Island
    Providence, United States
    Active

Researchers

  • Principal investigator: Chen, Xiaodi Felix — Women and Infants Hospital-Rhode Island
  • Study coordinator: Chen, Xiaodi Felix

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.